Commentary · 8 Oct 2025
Research articlePublished 2 Dec 2015
Effect of the Addition of Hand-Mixed Generic Vancomycin on Bone Cement Strength
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: No literature up to date has investigated on the mechanical strength of hand-mixed Vancomycin cement spacers. This puts to question the reliability of such practice in creating the spacers for load support in addition to Methicillinresistant Staphylococcus aureus (MRSA) coverage. Objective: The study compared the mechanical strength of hand-mixed generic Vancomycin bone cement with standard non-antibiotic bone cement. Methods: One (1) gram vials of generic Vancomycin powder were dry-blended with the cement powder (Cemex) following standard aseptic hospital practice (1 g Vancomycin in 40 g of cement powder). Samples for the cement-alone group were done similarly except for the addition of the antibiotic powder. Tensile and compression samples were created, soaked in saline, and stored at 37 degrees Celsius for one week. All samples were tested at the University of the Philippines College of Engineering Mechanical Laboratory for compressive and tensile strength. Acceptance or rejection of the null hypothesis was conducted using the t-test procedure performed on Minitab 15 Trial Version, with α of 0.05 as the level of significance. Results: T-test analysis performed on compressive strength data produced a p-value of 0.944 (α of 0.05), and on tensile strength data, 0.311 (α of 0.05). Conclusion: There is no effect of the addition of hand-mixed generic Vancomycin on the mechanical properties of the bone cement.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Annals of Clinical and Laboratory Research.
Mini review · 2 Oct 2025
Characteristics and Treatment of Juvenile Myasthenia Gravis
Commentary · 9 Jul 2025
Commentary on Upadacitinib in Difficult-to-Treat Psoriatic Arthritis: Real-World Data from 134 Patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAnnals of Clinical and Laboratory Research
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Mamer S. Rosario”
- BylineArticles whose byline prints “Venancio P. Garduce”
